Faricimab by Roche is a strong competitor to Eylea.
Molecular Partners
Posted inClinical Trials, COVID-19, Infections
Ensovibep: Drug for All Variants of Coronavirus Including Omicron
Molecular Partners and Novartis believe in the success of DARPins.
Posted inCOVID-19, Infections, Research
Omicron Variant: Latest Scientific News, Findings, Evidence, and Developments
Up-to-date scientific information about the new Omicron variant of SARS-CoV-2/COVID-19.